Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Virtual Event: The 340B drug discount program is at a crossroads. What’s next?

  • Rachel Cohrs

By Rachel Cohrs Sept. 15, 2021

Reprints

Editor’s note: A recording of the event is embedded below.

To advocates, this program supports safety net hospitals. Critics say some game the system.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rachel Cohrs

Rachel Cohrs

Washington Correspondent

Rachel reports on the intersection of politics and health policy.

Tags

Create a display name to comment

This name will appear with your comment

People with terminal cancer need to know they are…
People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information
Your questions on the new Covid vaccine boosters answered
Your questions on the new Covid vaccine boosters answered
A Q&A with WHO’s Maria Van Kerkhove on Covid…
A Q&A with WHO’s Maria Van Kerkhove on Covid — and fatigue over the pandemic
As hospitals raise their prices, U.S. workers and businesses…
As hospitals raise their prices, U.S. workers and businesses suffer
One Medical founder Tom Lee on the Amazon deal…
One Medical founder Tom Lee on the Amazon deal and striking the right balance with virtual…
The No Surprises Act: A Band-Aid protecting business as…
The No Surprises Act: A Band-Aid protecting business as usual

Recommended Stories